Skip to main content

The US Food and Drug Administration and Cardiovascular Medicine: Reflections and Observations.

Publication ,  Journal Article
Califf, RM
Published in: Circulation
August 16, 2016

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

August 16, 2016

Volume

134

Issue

7

Start / End Page

501 / 503

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Humans
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Cardiovascular Agents
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Califf, R. M. (2016). The US Food and Drug Administration and Cardiovascular Medicine: Reflections and Observations. Circulation, 134(7), 501–503. https://doi.org/10.1161/CIRCULATIONAHA.116.022137
Califf, Robert M. “The US Food and Drug Administration and Cardiovascular Medicine: Reflections and Observations.Circulation 134, no. 7 (August 16, 2016): 501–3. https://doi.org/10.1161/CIRCULATIONAHA.116.022137.
Califf, Robert M. “The US Food and Drug Administration and Cardiovascular Medicine: Reflections and Observations.Circulation, vol. 134, no. 7, Aug. 2016, pp. 501–03. Pubmed, doi:10.1161/CIRCULATIONAHA.116.022137.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

August 16, 2016

Volume

134

Issue

7

Start / End Page

501 / 503

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Humans
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Cardiovascular Agents
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services